Open access
Sep 2026
Serum HDGFL2 as a novel biomarker for disease activity in Egyptian patients with rheumatoid arthritis
Understanding the role of HDGFL2 in RA could provide novel insights into disease mechanisms and suggests that HDGFL2 is a promising exploratory biomarker for diagnosing RA and monitoring disease activity, potentially enhancing clinical management and therapeutic targeting.
Nesrine A. Helaly, N. Magdy, Mohamed S. Abdel-Latif et al.
· The Egyptian Journal of Inte... · 0 citations